HSHHSH Health Technology Supplier Hub
Home › Suppliers › Abridge › Risk

Abridge: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Apr 2026: a class action filed against Sutter Health alleges patients were not clearly told their consultations would be recorded through Abridge's ambient AI platform; Abridge is not reported as a defendant and no response was reported.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

Apr 2026: a California class action against Sutter Health alleges recording and sharing of patient conversations via Abridge's platform without clear notice (privacy claims); no data breach involving Abridge found in HSH's search. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

AI clinical documentation software supplier; no regulatory or clinical safety actions involving Abridge found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Sep 2026: the US Department of Veterans Affairs selected Abridge (alongside Knowtex) under a multi-vendor ambient AI enterprise contract with a shared ceiling of $775.72m, following pilots from Oct 2025.

Researched 10 Nov 2026